Cardiac Electrophysiology: From Cell to Bedside E-Book


Book Description

Rapid advancements in cardiac electrophysiology require today’s health care scientists and practitioners to stay up to date with new information both at the bench and at the bedside. The fully revised 7th Edition of Cardiac Electrophysiology: From Cell to Bedside, by Drs. Douglas Zipes, Jose Jalife, and William Stevenson, provides the comprehensive, multidisciplinary coverage you need, including the underlying basic science and the latest clinical advances in the field. An attractive full-color design features color photos, tables, flow charts, ECGs, and more. All chapters have been significantly revised and updated by global leaders in the field, including 19 new chapters covering both basic and clinical topics. New topics include advances in basic science as well as recent clinical technology, such as leadless pacemakers; catheter ablation as a new class I recommendation for atrial fibrillation after failed medical therapy; current cardiac drugs and techniques; and a new video library covering topics that range from basic mapping (for the researcher) to clinical use (implantations). Each chapter is packed with the latest information necessary for optimal basic research as well as patient care, and additional figures, tables, and videos are readily available online. New editor William G. Stevenson, highly regarded in the EP community, brings a fresh perspective to this award-winning text.




Integrated Electrophysical Agents[Formerly Entitled Electrotherapy: Evidence-Based Practice]


Book Description

Electrophysical Modalities (formerly Electrotherapy: Evidence-Based Practice) is back in its 13th edition, continuing to uphold the standard of clinical research and evidence base for which it has become renowned. This popular textbook comprehensively covers the use of electrotherapy in clinical practice and includes the theory which underpins that practice. Over recent years the range of therapeutic agents involved and the scope for their use have greatly increased and the new edition includes and evaluates the latest evidence and most recent developments in this fast-growing field. Tim Watson is joined by co-editor Ethne Nussbaum and both bring years of clinical, research and teaching experience to the new edition, with a host of new contributors, all leaders in their specialty.




Abstracts


Book Description




The Practice of Electroconvulsive Therapy


Book Description

Since the development of pharmacoconvulsive therapy in 1934 and of electroconvulsive therapy (ECT) in 1938, ECT has proven far more valuable than just the intervention of last resort. In comparison with psychotropic medications, we now know that ECT can act more effectively and more rapidly, with substantial clinical improvement that is often seen after only a few treatments. This is especially true for severely ill patients -- those with severe major depression with psychotic features, acute mania with psychotic features, or catatonia. For patients who are physically debilitated, elderly, or pregnant, ECT is also safer than psychotropic medications. The findings of the American Psychiatric Association (APA) Task Force on ECT were published by the APA in 1990 as the first edition of The Practice of Electroconvulsive Therapy, inaugurating the development of ECT guidelines by groups both within the United States and internationally. Since then, advances in the use of this technically demanding treatment prompted the APA to mandate a second edition. The updated format of this second edition presents background information followed by a summary of applicable recommendations for each chapter. This close integration of the recommendations with their justifications makes the material easy to read, understand, and use. To further enhance usability, recommendations critical to the safe, effective delivery of treatment are marked with the designation "should" to distinguish them from recommendations that are advisable but nonessential (with the designations "encouraged," "suggested," "considered"). The updated content of this second edition, which spans indication for use of ECT, patient evaluation, side effects, concurrent medications, consent procedures (with sample consent forms and patient information booklet), staffing, treatment administration, monitoring of outcome, management of patients following ECT, and documentation, as well as education, and clinical privileging. This volume reflects not only the wide expertise of its contributors, but also involved solicitation of input from a variety of other sources, including applicable medical professional organizations, individual experts in relevant fields, regulatory bodies, and major lay mental health organizations. In addition, the bibliography of this second edition is based upon an exhaustive search of the clinical ECT literature over the past decade and contains more than four times the original number of citations. Complemented by extensive annotations and useful appendixes, this remarkably comprehensive yet practical overview will prove an invaluable resource for practitioners and trainees in psychiatry and related disciplines.




New Frontiers in Biomagnetism


Book Description

NEW FRONTIERS IN BIOMAGNETISM contains selected papers based on presentations at the 15th International Conference on Biomagnetism (Biomag 2006), held in Vancouver between the 20th and 26th of August, 2006. The conference brought together over 500 scientists and specialists from around the world to present the latest scientific and technological developments in the field of Biomagnetism - the measurement of magnetic signals produced by electric currents in the human body. The study of the minute magnetic fields resulting from heart and muscle contraction, signal conduction in the nervous system, or by the magnetization of biological tissue has grown steadily since the 5th World Conference on Biomagnetism that was held in Vancouver in August of 1984.Although the conference covered many facets of biomagnetism research, the focus for this year's conference was on new frontiers in biomagnetism - the development of new applications and areas of research. One emphasis was on the application of Magnetoencephalography (MEG) to the study of human development and its potential to help understand the physiological underpinnings of language and cognitive development in children, including neurodevelopmental disorders, such as Down Syndrome, autism and language impairment. There were also many exciting contributions on the latest techniques for the precise localization of brain activity using MEG, and related methods for the study of brain dynamics and distributed networks of neural activity. These novel approaches to the study of human brain function promise to provide new insights into the organization of neural systems underlying motor planning, perception, memory and cognition. Other areas of rapid development discussed in New Frontiers in Biomagnetism include the application of biomagnetic measures in the diagnosis and treatment of epilepsy, psychiatric disorders such as schizophrenia, and the use of MEG for presurgical functional mapping. Special sessions were also dedicated to the latest developments in Magnetocardiography (MCG) for the assessment of cardiovascular disease and associated disorders of the electrical activity of the heart. This year's conference also held a special symposium in honour of the late Sam Williamson, with presentations from his former colleagues and students that reviewed his life's work and contributions to the field of neuromagnetism. NEW FRONTIERS IN BIOMAGNETISM aims to provide a comprehensive overview of the latest developments in the field of Biomagnetism and its application to the study of human biological systems. The many new developments and breakthroughs presented at Biomag 2006 made a significant contribution to the advancement of the understanding of brain and cardiac function and provided new tools for clinical applications of this new knowledge.




Ventricular Arrhythmias


Book Description

Ventricular arrhythmias cause most cases of sudden cardiac death, which is the leading cause of death in the US. This issue reviews the causes of arrhythmias and the promising new drugs and devices to treat arrhythmias.